Published :
Tables : 110
Figures : 40
Category : Healthcare
No. of Pages : 224
Report Code : HC-1176
Next-Generation Sequencing (NGS) Market Introduction: Next Generation Sequencing (NGS) Sample Preparation Market is anticipated to value over USD 3.2 billion with a CAGR of over 17% during the forecast period 2020-2027. Genetics has a large scope in current as well as future research and development. Next generation sequencing (NGS) is a rapidly growing stream in genetic research. It's a parallel sequencing method used to make a whole human genome rapidly. The functional annotations in genetic mutations have become easy with NGS projects. The NGS sample preparation market has a wide scope currently and in the future also. The recent studies and research on NGS sample preparation is the key factor driving its market growth. The different research organizations get funds for their NGS sample preparation projects by both government and non-government bodies. The library preparation and target enrichment get more focus as compared to other product types of the market. To improve the recent traditional diagnostic and treatment methods both play a key role. Target enrichment provides patient compliance in case cancer and tumour treatments as the affected area is targeted directly with reduced harm to other organs. Drug discovery in NGS sample preparation is a major sector as it gets massive funds and demand in the market. Various biomarkers, DNA fragments can be used for discovering new drugs. Also because of such extensive market demand, the research and diagnostic centres also play a key role in driving market growth. North America, Europe and Asia Pacific are dominating regions in global NGS sample preparation market. The rising genetic disorders and patient population along with awareness and the research developments, these regions are anticipated to have a large market share. Key players in the market are: Agilent Technologies, Inc. Becton, Dickinson and Company Beckman Coulter (A Subsidiary of Danaher) F. Hoffmann-La Roche AG, Illumina, Inc., New England Biolabs, Inc., Nugen Technologies, Inc. (Part of Tecan Trading Ag), Oxford Gene Technology (Part of Sysmex), Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., Perkinelmer, Inc., QIAGEN N.V., Raindance Technologies, Inc. (Part of Bio-Rad Laboratories), Swift Biosciences Inc., Thermo Fisher Scientific Inc.. Agilent Technologies is anticipated to have a major market share. It has a range of advanced NGS assays for diagnosis of cancer, target enrichment probes, NGS software, NGS quality control, and so on. The availability of these facilities by Agilent Technologies is the key factor driving its market growth in NGS sample preparation across the globe. Next Generation Sequencing (NGS) Sample Preparation Market Segmentation: By Product Workstations Reagents & Consumables By Workflow Library Preparation DNA Human Whole Genome Sequencing (WGS) Targeted Sequencing Whole Exome Sequencing (WES) Others RNA Gene Expression Analysis Whole Transcriptome Sequencing Others Target Enrichment Targeted Seq WES Others Quality Control By Technology Sequencing by Synthesis (SBS) Ion Semiconductor Sequencing Single-molecule Real-time (SMRT) Sequencing Nanopore Sequencing Other Technologies By End User Academic Institutes and Research Centers Hospitals & Clinics Pharmaceutical & Biotechnology Companies Other End Users (Includes non-profit organizations, agrigenomics organizations, reference laboratories, and consumer genomics companies, among others) By Application Disease Diagnostics Cancer Diagnostics Reproductive Health Diagnostics Infectious Disease Diagnostics Other Disease Diagnostic Applications Drug Discovery Agricultural and Animal Research Other Applications By Region North America Latin America Europe Asia-Pacific Middle East and Africa Competitive Landscape: Agilent Technologies has provided NGS assays for the detection of somatic cancer and is expected to be the key factos Agilent Technologies has a target enrichment probe that targets 151 key genes associated with a wide range of cancers FutureWise Key Takeaways: Drug discovery based on NGS sample preparation More focus on target enrichment techniques Objectives of the Study: To provide with an exhaustive analysis on the next generation sequencing (NGS) sample preparation market by product, by workflow, by technology, by end user, by application and by region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe and the rest of the world. To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Next Generation Sequencing (NGS) Sample Preparation Market is anticipated to value over USD 3.2 billion with a CAGR of over 17% during the forecast period 2020-2027.
Genetics has a large scope in current as well as future research and development. Next generation sequencing (NGS) is a rapidly growing stream in genetic research. It's a parallel sequencing method used to make a whole human genome rapidly. The functional annotations in genetic mutations have become easy with NGS projects.
The NGS sample preparation market has a wide scope currently and in the future also. The recent studies and research on NGS sample preparation is the key factor driving its market growth. The different research organizations get funds for their NGS sample preparation projects by both government and non-government bodies.
The library preparation and target enrichment get more focus as compared to other product types of the market. To improve the recent traditional diagnostic and treatment methods both play a key role. Target enrichment provides patient compliance in case cancer and tumour treatments as the affected area is targeted directly with reduced harm to other organs.
Drug discovery in NGS sample preparation is a major sector as it gets massive funds and demand in the market. Various biomarkers, DNA fragments can be used for discovering new drugs. Also because of such extensive market demand, the research and diagnostic centres also play a key role in driving market growth.
North America, Europe and Asia Pacific are dominating regions in global NGS sample preparation market. The rising genetic disorders and patient population along with awareness and the research developments, these regions are anticipated to have a large market share.
Key players in the market are: Agilent Technologies, Inc. Becton, Dickinson and Company Beckman Coulter (A Subsidiary of Danaher) F. Hoffmann-La Roche AG, Illumina, Inc., New England Biolabs, Inc., Nugen Technologies, Inc. (Part of Tecan Trading Ag), Oxford Gene Technology (Part of Sysmex), Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., Perkinelmer, Inc., QIAGEN N.V., Raindance Technologies, Inc. (Part of Bio-Rad Laboratories), Swift Biosciences Inc., Thermo Fisher Scientific Inc..
Agilent Technologies is anticipated to have a major market share. It has a range of advanced NGS assays for diagnosis of cancer, target enrichment probes, NGS software, NGS quality control, and so on. The availability of these facilities by Agilent Technologies is the key factor driving its market growth in NGS sample preparation across the globe.
Next Generation Sequencing (NGS) Sample Preparation Market Segmentation:
By Product
By Workflow
By Technology
By End User
By Application
By Region
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Next-Generation Sequencing (NGS) Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Next-Generation Sequencing (NGS) Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Next-Generation Sequencing (NGS) Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Next-Generation Sequencing (NGS) Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Workstations 7.2. Reagents & Consumables 8. Global Next-Generation Sequencing (NGS) Market, By Workflow Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Library Preparation 8.1.1. DNA 8.1.1.1. Human Whole Genome Sequencing (WGS) 8.1.1.2. Targeted Sequencing 8.1.1.3. Whole Exome Sequencing (WES) 8.1.1.4. Others 8.1.2. RNA 8.1.2.1. Gene Expression Analysis 8.1.2.2. Whole Transcriptome Sequencing 8.1.2.3. Others 8.1.3. Target Enrichment 8.1.3.1. Targeted Seq 8.1.3.2. WES 8.1.3.3. Others 8.1.4. Quality Control 9. Global Next-Generation Sequencing (NGS) Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Disease Diagnostics 9.1.1. Cancer Diagnostics 9.1.2. Reproductive Health Diagnostics 9.1.3. Infectious Disease Diagnostics 9.1.4. Other Disease Diagnostic Applications 9.2. Drug Discovery 9.3. Agricultural and Animal Research 9.4. Other Applications 10. Global Next-Generation Sequencing (NGS) Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Sequencing by Synthesis (SBS) 10.2. Ion Semiconductor Sequencing 10.3. Single-molecule Real-time (SMRT) Sequencing 10.4. Nanopore Sequencing 10.5. Other Technologies 11. Global Next-Generation Sequencing (NGS) Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 11.1. Academic Institutes and Research Centers 11.2. Hospitals & Clinics 11.3. Pharmaceutical & Biotechnology Companies 11.4. Other End Users (Includes non-profit organizations, agrigenomics organizations, reference laboratories, and consumer genomics companies, among others) 12. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2020-2027 13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2020-2027 14. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Switzerland 14.2.9. Rest of Western Europe 15. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Japan 15.2.2. China 15.2.3. Singapore 15.2.4. India 15.2.5. Australia and New Zealand 15.2.6. ASEAN 15.2.7. South Korea 15.2.8. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 16.2.1. Saudi Arabia 16.2.2. UAE 16.2.3. South Africa 16.2.4. Egypt 16.3. Market Size (USD Million) Forecast for MEA 2020-2027 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 17.1. Agilent Technologies, Inc. 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Becton, Dickinson and Company 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Beckman Coulter (A Subsidiary of Danaher) 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. F. Hoffmann-La Roche AG 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Illumina, Inc. 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. New England Biolabs, Inc. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Nugen Technologies, Inc. (Part of Tecan Trading Ag) 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Oxford Gene Technology (Part of Sysmex) 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Oxford Nanopore Technologies, Ltd. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10. Pacific Biosciences of California, Inc. 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11. Perkinelmer, Inc 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12. QIAGEN N.V. 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13. Raindance Technologies, Inc. (Part of Bio-Rad Laboratories) 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14. Swift Biosciences Inc. 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15. Thermo Fisher Scientific Inc. 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview 18. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics